Based in All, Ikerian is a startup founded in 2016. Brouky records 1 investor associated with the company.
Ikerian provides an AI-driven healthcare software platform called Discovery that organizes and harmonizes multimodal and unstructured medical data at scale to extract biomarkers, monitor and predict disease outcomes, and optimize clinical workflows. Their modular platform is used by pharmaceutical companies, device manufacturers, clinics, CROs and research institutions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.